Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Innovative Medicines for Cardiovascular Disease
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 27, 2019--Blackstone Life Sciences today announced the launch of Anthos Therapeutics Inc. ("Anthos"), a new biopharmaceutical company focused…
